Flu Hospitalization Rate Week 25 Hit 87.7 | Lines.com

The CDC confirmed a cumulative flu hospitalization rate of 87.7 per 100,000 population for Week 25 of the 2025-2026 flu season, ending June 27, 2026. That figure landed squarely in the 85-90 bracket, resolving this Polymarket contract YES. The FluView report was delayed until July 6 due to the federal holiday, which pushed the market’s final confirmation past the original end date of July 3.

Traders priced this outcome at 96% when the market opened and held near that level for most of the contract’s life. The implied probability sat at 99.7% by resolution, and total volume reached $5,526, a modest figure that reflects the narrow analytical window this type of measurement market offers. The market got it right, and the price history shows traders largely knew it.

CDC FluSurv-NET Confirmed the 85-90 Hospitalization Bracket

FluSurv-NET, the CDC’s population-based laboratory-confirmed influenza hospitalization network, reported 30,571 total hospitalizations between October 1, 2025, and June 27, 2026. The cumulative rate of 87.7 per 100,000 population placed the season comfortably within the 85-90 range. The weekly rate for Week 25 itself was just 0.1 per 100,000, confirming the 2025-2026 flu season had wound down by that point. No new human infections with avian influenza A(H5) virus were reported during the same week.

The final 5.2% price jump occurred on July 6, the day CDC published the delayed FluView report. Before that release, the market held around 95-96 cents. The move to 1.00 was immediate and clean. Traders were not guessing at close: they were waiting for a federal agency to post data that was already a week old.

Sponsored Partner

How the Market Performed on a Measurement Contract

The market opened at 96 cents and implied a 99.7% probability by resolution. Traders correctly favored the 85-90 bracket throughout the contract. The structure here is not about forecasting a binary event: it is about estimating where a known trailing metric would settle. That changes the nature of market accuracy. A 96% open price is not a prediction, it is a confidence interval.

Total volume of $5,526 with $8,454 in liquidity signals reasonable price discovery for a niche measurement market. The volume is thin compared to marquee science contracts, but that is expected. Flu hospitalization bucket markets draw specialists who track FluSurv-NET data, not broad audiences. The $1,334 in 24-hour volume on July 6 shows the CDC publication triggered the final settlement trades.

What the 87.7 Rate Means for Flu Season Tracking

The 2025-2026 flu season accumulated 87.7 hospitalizations per 100,000 people by late June. FluSurv-NET represents roughly 10% of the U.S. population across select counties in 14 states, so that figure carries real epidemiological weight. A weekly rate of 0.1 per 100,000 in Week 25 confirms the season had passed its peak well before summer. The absence of any new avian influenza A(H5) detections keeps the pandemic risk signal quiet for now.

For prediction market purposes, flu hospitalization rate contracts expose an interesting structural quirk. The outcome was knowable to anyone monitoring FluSurv-NET cumulative data in real time. The July 4 federal holiday created a 72-hour information gap between the market end date and the CDC publication. That gap is where the residual 4% uncertainty at open lived. Here’s what the measurements are telling us: the data doesn’t care about the politics of publication calendars.

• CDC FluSurv-NET will update Week 25 data as additional reports arrive from its 14-state network, and the 87.7 figure remains preliminary.
• The 2025-2026 season’s cumulative rate of 87.7 per 100,000 places it in context with prior seasons tracked on FluView Interactive, which analysts use to benchmark severity.
• The absence of new A(H5) avian flu detections in Week 25 keeps pandemic preparedness markets, such as the 2% Hantavirus contract, appropriately priced at low probability.
• Week 26 and subsequent FluView reports will confirm whether late-season cases push the final cumulative rate beyond 90 per 100,000 before the season closes.

LINES RESOLUTION VERDICT

CORRECTLY PRICED YES

Traders identified the 85-90 bucket early and held conviction through a federal publication delay, producing a clean resolution at 87.7 per 100,000. The market is pricing uncertainty, not science, and here the science was already written in the FluSurv-NET cumulative totals.

What the market showed: The implied probability opened at 96% and closed at 99.7%. The actual outcome of 87.7 per 100,000 confirmed the YES resolution. Traders correctly priced this measurement bracket throughout the contract’s life, with the final move to 1.00 driven by CDC data publication on July 6.